![T2D: Don’t Sugar Coat It podcast](/assets/images/square.png)
What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
Faculty Presenters:
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee
Javier Morales, MD, FACP, FACE
Internal Medicine, Diabetes, and Primary Care
Associate Clinical Professor
Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
Long Island, New York
Richard E. Pratley, MD
Internal Medicine and Diabetes
AdventHealth Diabetes Institute
Orlando, Florida
Flere episoder fra "T2D: Don’t Sugar Coat It"
Gå ikke glip af nogen episoder af “T2D: Don’t Sugar Coat It” - abonnér på podcasten med gratisapp GetPodcast.